Abstract Body

Background: The mechanisms that drive immune activation in HIV-1-infection remain unclear. We have recently shown that HIV-1-infected subjects have dysfunctional (oxidized) HDL that is associated with biomarkers of T cell activation. Herein, we investigated whether in vivo modified native dysfunctional HDL from HIV-1 infected subjects (HIV-HDL) and in vitro oxidized HDL (HDLox) directly upregulate T cell proliferation and activation in vitro. Methodology: HIV-HDL was isolated from HIV-1 infected subjects (n=8) with suppressed viremia (HIV-1 RNA <50 copies/mL) on antiretroviral therapy (ART) known to have dysfunctional HDL based on a validated biochemical assay. Pooled HDL from healthy subjects was oxidized in vitro using an in vivo generated potent lipid oxidant (Drug Metab Lett. 2010; 4:139-48)(HDLox). Peripheral blood mononuclear cells (PBMCs) from HIV-1 infected (n=15) subjects with suppressed viremia on ART and uninfected (n=15) subjects were incubated with serum free media, anti-CD3 antibody and IL-2 for 72 hours with or without HIV-HDL, HDLox (6.25 ug/ml). Immune activation and proliferation index (PI) was assessed on T cells (#CD38/cell, % CD38+DR+ cells) of HIV-1 infected and uninfected subjects using flow cytometry and the Quantibrite method. Paired T-test was used for comparison of values between pairs. Results: All HIV infected subjects were male, 65.2% were white with a median age 41 (range 18-58), median CD4+ T cells 510 cells/mm3 (IQR: 401-620). Addition of HDLox, HIV-HDL significantly (p<0.01) increased #CD38 on CD8+ T cells (Figure, Medians are shown), % CD38+DR+ CD8+ T-cells (not shown) compared to addition of normal HDL. Similar results were found in CD4+ T cells (not shown). Compared to HDL, HDLox directly increased PI of T cells (median 1.45 vs 1.31, p<0.001), T cell expression of INF-γ (median 12.3% vs 8.7% INF-γ+ T cells, p<0.01) and IL-2 (median 7.13% vs 5.37% IL-2+ T cells, p<0.01) and expression of both CXCR4 (median fluorescence intensity [MFI] 757 vs 679, p<0.001) and CCR5 (MFI 200 vs 164, p<0.01) on CD4+ T cells in HIV-1 infected but not in uninfected subjects. Conclusions: Our results suggest a costimulatory effect of dysfunctional HDL on T cells of HIV-1-infected subjects with suppressed viremia on ART. Since HIV-1 infected subjects have dysfunctional HDL compared to uninfected subjects, further studies are warranted to evaluate whether modified lipoproteins may contribute to T cell activation in HIV-1 infection despite successful virologic therapy.